Search

Eric K. Nicholson

Examiner (ID: 1800)

Most Active Art Unit
3501
Art Unit(s)
3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679
Total Applications
2110
Issued Applications
1732
Pending Applications
114
Abandoned Applications
263

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8690160 [patent_doc_number] => 08389689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Anti-GLP-1R antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 12/913406 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6964 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12913406 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/913406
Anti-GLP-1R antibodies and their uses Oct 26, 2010 Issued
Array ( [id] => 5952372 [patent_doc_number] => 20110033464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/910146 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9376 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033464.pdf [firstpage_image] =>[orig_patent_app_number] => 12910146 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/910146
IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS Oct 21, 2010 Abandoned
Array ( [id] => 5944200 [patent_doc_number] => 20110104820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Tyrosine, Serine, And Threonine Phosphorylation Sites' [patent_app_type] => utility [patent_app_number] => 12/902261 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27790 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104820.pdf [firstpage_image] =>[orig_patent_app_number] => 12902261 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/902261
Tyrosine, Serine, And Threonine Phosphorylation Sites Oct 11, 2010 Abandoned
Array ( [id] => 6149782 [patent_doc_number] => 20110021377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'USE OF A TRPC CHANNEL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/897892 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5974 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021377.pdf [firstpage_image] =>[orig_patent_app_number] => 12897892 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/897892
Treating cardiovascular disease with TRPC3 channel protein Oct 4, 2010 Issued
Array ( [id] => 5992544 [patent_doc_number] => 20110014197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA' [patent_app_type] => utility [patent_app_number] => 12/892652 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30487 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014197.pdf [firstpage_image] =>[orig_patent_app_number] => 12892652 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/892652
METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA Sep 27, 2010 Abandoned
Array ( [id] => 5977714 [patent_doc_number] => 20110071089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/886397 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21651 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071089.pdf [firstpage_image] =>[orig_patent_app_number] => 12886397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/886397
Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity Sep 19, 2010 Issued
Array ( [id] => 8385955 [patent_doc_number] => 08263349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/804664 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 14575 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12804664 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/804664
Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof Jul 26, 2010 Issued
Array ( [id] => 8183969 [patent_doc_number] => 20120114595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 13/383845 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18336 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114595.pdf [firstpage_image] =>[orig_patent_app_number] => 13383845 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/383845
SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME Jul 11, 2010 Abandoned
Array ( [id] => 6439411 [patent_doc_number] => 20100279331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Novel Transporter Protein in Mammal and Utilization of the Same' [patent_app_type] => utility [patent_app_number] => 12/817576 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21363 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279331.pdf [firstpage_image] =>[orig_patent_app_number] => 12817576 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/817576
Transporter protein in mammal and utilization of the same Jun 16, 2010 Issued
Array ( [id] => 10062294 [patent_doc_number] => 09101117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto' [patent_app_type] => utility [patent_app_number] => 13/377277 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 26 [patent_no_of_words] => 36040 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377277 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/377277
SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto Jun 9, 2010 Issued
Array ( [id] => 8201078 [patent_doc_number] => 08188081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Methods of treating inflammation using prokineticin 1 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/797266 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 35 [patent_no_of_words] => 33529 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188081.pdf [firstpage_image] =>[orig_patent_app_number] => 12797266 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/797266
Methods of treating inflammation using prokineticin 1 receptor antagonists Jun 8, 2010 Issued
Array ( [id] => 6542145 [patent_doc_number] => 20100287672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PLANT CELL SIGNALING GENES' [patent_app_type] => utility [patent_app_number] => 12/786876 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 215 [patent_figures_cnt] => 215 [patent_no_of_words] => 52160 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20100287672.pdf [firstpage_image] =>[orig_patent_app_number] => 12786876 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/786876
Plant cell signaling genes May 24, 2010 Issued
Array ( [id] => 6185001 [patent_doc_number] => 20110123986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS' [patent_app_type] => utility [patent_app_number] => 12/778010 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 78217 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123986.pdf [firstpage_image] =>[orig_patent_app_number] => 12778010 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/778010
METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS May 10, 2010 Abandoned
Array ( [id] => 6235348 [patent_doc_number] => 20100267052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 12/776601 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 59645 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267052.pdf [firstpage_image] =>[orig_patent_app_number] => 12776601 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/776601
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES May 9, 2010 Abandoned
Array ( [id] => 6326889 [patent_doc_number] => 20100197596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Compositions and methods for diagnosis and treatment of type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 12/759072 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 47299 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197596.pdf [firstpage_image] =>[orig_patent_app_number] => 12759072 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/759072
Methods for treatment of type 2 diabetes Apr 12, 2010 Issued
Array ( [id] => 6339994 [patent_doc_number] => 20100247536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR ANTIBODIES FOR DIAGNOSTIC AND CLINICAL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/732880 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14692 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247536.pdf [firstpage_image] =>[orig_patent_app_number] => 12732880 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/732880
Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications Mar 25, 2010 Issued
Array ( [id] => 7696192 [patent_doc_number] => 20110230398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders' [patent_app_type] => utility [patent_app_number] => 12/727339 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1911 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230398.pdf [firstpage_image] =>[orig_patent_app_number] => 12727339 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/727339
Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders Mar 18, 2010 Abandoned
Array ( [id] => 8197059 [patent_doc_number] => 20120121591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3' [patent_app_type] => utility [patent_app_number] => 13/258454 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 81 [patent_no_of_words] => 92236 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121591.pdf [firstpage_image] =>[orig_patent_app_number] => 13258454 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/258454
SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 Mar 18, 2010 Abandoned
Array ( [id] => 6622687 [patent_doc_number] => 20100311077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Use of GPR100 Receptor in Diabetes and Obesity Regulation' [patent_app_type] => utility [patent_app_number] => 12/725415 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31226 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311077.pdf [firstpage_image] =>[orig_patent_app_number] => 12725415 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/725415
Use of GPR100 Receptor in Diabetes and Obesity Regulation Mar 15, 2010 Abandoned
Array ( [id] => 6188686 [patent_doc_number] => 20110171627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/723364 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48532 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171627.pdf [firstpage_image] =>[orig_patent_app_number] => 12723364 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/723364
ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS Mar 11, 2010 Abandoned
Menu